'Biosimilar naming' presentation slideshows

U.S. and European Physician Perspectives on Biosimilar Naming and Substitution

U.S. and European Physician Perspectives on Biosimilar Naming and Substitution. Michael S. Reilly, Esq. Executive Director, Alliance for Safe Biologic Medicines Presented at the Food and Drug Law Institute 57 th Annual Conference April 23, 2014 Washington, DC . ASBM.

376 views • 26 slides